Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | NT5E | P21589 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27433721 | 1.00 | CA5A (0.39) | CA5ACA5BTSHRCA1CA2 | |
| Water SCHEMBL384922 | 0.96 | CA5A (0.36) | CA5ACA5BTSHRCA1CA2 | |
| SCHEMBL16756653 | 0.96 | CA5A (0.36) | CA5ACA5BTSHRCA1CA2 | |
| SCHEMBL29170918 | 0.96 | CA5A (0.36) | CA5ACA5BTSHRCA1CA2 | |
| SCHEMBL2571875 | 0.96 | CA5A (0.36) | CA5ACA5BTSHRCA1CA2 | |
| SCHEMBL14974666 | 0.96 | CA5A (0.36) | CA5ACA5BTSHRCA1CA2 | |
| Ammonia Solution, Strong SCHEMBL5760496 | 0.96 | CA5A (0.36) | CA5ACA5BTSHRCA1CA2 | |
| Water SCHEMBL1614964 | 0.96 | CA5A (0.36) | CA5ACA5BTSHRCA1CA2 | |
| SCHEMBL17510158 | 0.96 | CA5A (0.36) | CA5ACA5BTSHRCA1CA2 | |
| Hydrochloric Acid SCHEMBL27895967 | 0.96 | CA5A (0.36) | CA5ACA5BTSHRCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14345 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120754262-B | Nucleic acid delivery vector and preparation method and application thereof | Shenzhen Jinlin Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122070275-A | Heterocyclic compound and application thereof | 成都麻沸散医药科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122070278-A | Bifunctional protein degradation agent containing aryl substituted heteroaryl and application thereof | 标新生物医药科技(上海)有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122059854-A | Guanidino cyclohexane derivative and preparation method and application thereof | 安徽益普克医药科技发展有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122055357-A | Heterocyclic compound and application thereof | 成都麻沸散医药科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026098592-A1 | USE OF HETEROCYCLIC COMPOUND AND COMPLEX FORMED BY HETEROCYCLIC COMPOUND AND PHARMACEUTICALLY ACCEPTABLE ACID | 湖北生物医药产业技术研究院有限公司 | 2026-05-15 | — | — | WO | claimed |
| WO-2026098600-A1 | FORMULATION CONTAINING HETEROCYCLIC COMPOUND OR COMPLEX FORMED FROM HETEROCYCLIC COMPOUND AND PHARMACEUTICALLY ACCEPTABLE SALT, PREPARATION METHOD THEREFOR, AND USE THEREOF | 湖北生物医药产业技术研究院有限公司 | 2026-05-15 | — | — | WO | claimed |
| US-20260109671-A1 | BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME | CURASEN THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | claimed |
| EP-4711372-A1 | CRYSTAL FORM OF HETEROCYCLIC COMPOUND, SALT THEREOF, CRYSTAL FORM OF SALT THEREOF, AND USE | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. (CN) | 2026-03-18 | — | — | EP | claimed |
| WO-2026044024-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF | I2O THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| US-4649199-A | ANTITUMOR | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1987-03-10 | — | — | US | claimed |
| CN-85101161-A | Petroleum recovery composition | — | 1986-09-03 | — | — | CN | claimed |
| EP-0190587-A1 | Soluble quinazolino-1,4-benzodiazepin-5,13-dione derivatives, process for their preparation and pharmaceutical composition containing them | MERCK & CO. INC. (US) | 1986-08-13 | — | — | EP | claimed |
| EP-0189803-A1 | Indol-3-yl-quinazolino-1,4-benzodiazepin-5,13-diones, process for their preparation and pharmaceutical compositions containing them | MERCK & CO. INC. (US) | 1986-08-06 | — | — | EP | claimed |
| EP-0189802-A1 | Quinazolino-1,4-benzodiazepin-5,13-diones, processes for their preparation and pharmaceutical compositions containing them | MERCK & CO. INC. (US) | 1986-08-06 | — | — | EP | claimed |
| US-4563451-A | ANTAGONISTS OF CHOLECYSTOKININS | MERCK & CO., INC. (US) | 1986-01-07 | — | — | US | claimed |
| US-4559338-A | Soluble quinazolino-1,4-benzodiazepin-5,13-dione derivatives | MERCK & CO., INC. (US) | 1985-12-17 | — | — | US | claimed |
| US-4559339-A | CENTRAL NERVOUS SYSTEM, GASTROINTESTINAL DISORDERS | MERCK & CO., INC. (US) | 1985-12-17 | — | — | US | claimed |
| EP-0157126-A1 | A salt of DC-52 and a pharmaceutical composition containing the same | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1985-10-09 | — | — | EP | claimed |
| US-4370338-A | ANTICONVULSANT, ANXIOLYTIC, AND HYPNOTIC; RILUZOLE | PHARMINDUSTRIE (FR) | 1983-01-25 | — | — | US | claimed |